Cargando…

OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)

BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Lucy Boyce, Van Swearingen, Amanda E D, Sheng, Jeff, Zhang, Dadong, Qin, Xiaodi, Lipp, Eric, Kumar, Swaminathan, Zhang, Gao, Hanks, Brent, Davies, Michael, Owzar, Kouros, Anders, Carey K, Salama, April K S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351192/
http://dx.doi.org/10.1093/noajnl/vdab071.069
_version_ 1783735920030121984
author Kennedy, Lucy Boyce
Van Swearingen, Amanda E D
Sheng, Jeff
Zhang, Dadong
Qin, Xiaodi
Lipp, Eric
Kumar, Swaminathan
Zhang, Gao
Hanks, Brent
Davies, Michael
Owzar, Kouros
Anders, Carey K
Salama, April K S
author_facet Kennedy, Lucy Boyce
Van Swearingen, Amanda E D
Sheng, Jeff
Zhang, Dadong
Qin, Xiaodi
Lipp, Eric
Kumar, Swaminathan
Zhang, Gao
Hanks, Brent
Davies, Michael
Owzar, Kouros
Anders, Carey K
Salama, April K S
author_sort Kennedy, Lucy Boyce
collection PubMed
description BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package was used to perform differential gene expression (DGE) analyses. Pathway analysis was performed using Gene Set Enrichment Analysis (GSEA). Paired DGE and GSEA compared MBM vs. lymph node (LN) metastases (n = 16) and MBM vs. skin mets (n = 10). CIBERSORTx estimated relative abundance of immune cell types in MBM and ECM. GATK Mutect2 pipeline was used to call somatic mutations using paired normal tumor samples. Mutations were annotated using the Ensembl Variant Effect Predictor and visualized using the Maftools package in R. RNA-seq was available on 54 human primary cutaneous melanomas (CM). Gene Ontology or KEGG Pathway analysis was performed using goana function of limma package in R. RESULTS: Paired GSEA found that autophagy pathways may be up-regulated in MBM vs. LN and MBM vs. skin mets. On a single-gene level, the most strongly up-regulated genes in autophagy pathways were GFAP and HBB. Fold changes in other autophagy-related genes were low and did not reach significance. Comparison between CM which recurred in brain vs. CM which did not recur identified up-regulation of autophagy pathways. CIBERSORTx identified an increased proportion of immune suppressive M2 macrophages compared to tumor suppressive M1 macrophages in MBMs and ECMs. CONCLUSION: Up-regulation of autophagy pathways was observed in patient-matched MBM vs. LN and skin mets. This finding was driven by up-regulation of GFAP and HBB, which could reflect changes in the tumor microenvironment. Higher M2:M1 ratio may contribute to an immune suppressive tumor microenvironment and may be targetable. Validation of our findings in an independent Duke dataset is ongoing.
format Online
Article
Text
id pubmed-8351192
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-83511922021-08-09 OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM) Kennedy, Lucy Boyce Van Swearingen, Amanda E D Sheng, Jeff Zhang, Dadong Qin, Xiaodi Lipp, Eric Kumar, Swaminathan Zhang, Gao Hanks, Brent Davies, Michael Owzar, Kouros Anders, Carey K Salama, April K S Neurooncol Adv Supplement Abstracts BACKGROUND: MBM have a unique molecular profile compared to ECM. METHODS: We analyzed a previously published dataset from MD Anderson Cancer Center, including RNA-seq on surgically resected, FFPE MBM and ECM from the same patients. STAR pipeline was used to estimate mRNA abundance. DESeq2 package was used to perform differential gene expression (DGE) analyses. Pathway analysis was performed using Gene Set Enrichment Analysis (GSEA). Paired DGE and GSEA compared MBM vs. lymph node (LN) metastases (n = 16) and MBM vs. skin mets (n = 10). CIBERSORTx estimated relative abundance of immune cell types in MBM and ECM. GATK Mutect2 pipeline was used to call somatic mutations using paired normal tumor samples. Mutations were annotated using the Ensembl Variant Effect Predictor and visualized using the Maftools package in R. RNA-seq was available on 54 human primary cutaneous melanomas (CM). Gene Ontology or KEGG Pathway analysis was performed using goana function of limma package in R. RESULTS: Paired GSEA found that autophagy pathways may be up-regulated in MBM vs. LN and MBM vs. skin mets. On a single-gene level, the most strongly up-regulated genes in autophagy pathways were GFAP and HBB. Fold changes in other autophagy-related genes were low and did not reach significance. Comparison between CM which recurred in brain vs. CM which did not recur identified up-regulation of autophagy pathways. CIBERSORTx identified an increased proportion of immune suppressive M2 macrophages compared to tumor suppressive M1 macrophages in MBMs and ECMs. CONCLUSION: Up-regulation of autophagy pathways was observed in patient-matched MBM vs. LN and skin mets. This finding was driven by up-regulation of GFAP and HBB, which could reflect changes in the tumor microenvironment. Higher M2:M1 ratio may contribute to an immune suppressive tumor microenvironment and may be targetable. Validation of our findings in an independent Duke dataset is ongoing. Oxford University Press 2021-08-09 /pmc/articles/PMC8351192/ http://dx.doi.org/10.1093/noajnl/vdab071.069 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Supplement Abstracts
Kennedy, Lucy Boyce
Van Swearingen, Amanda E D
Sheng, Jeff
Zhang, Dadong
Qin, Xiaodi
Lipp, Eric
Kumar, Swaminathan
Zhang, Gao
Hanks, Brent
Davies, Michael
Owzar, Kouros
Anders, Carey K
Salama, April K S
OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title_full OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title_fullStr OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title_full_unstemmed OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title_short OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)
title_sort othr-14. an immunogenomic analysis of melanoma brain metastases (mbm) compared to extracranial metastases (ecm)
topic Supplement Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351192/
http://dx.doi.org/10.1093/noajnl/vdab071.069
work_keys_str_mv AT kennedylucyboyce othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT vanswearingenamandaed othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT shengjeff othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT zhangdadong othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT qinxiaodi othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT lipperic othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT kumarswaminathan othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT zhanggao othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT hanksbrent othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT daviesmichael othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT owzarkouros othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT anderscareyk othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm
AT salamaaprilks othr14animmunogenomicanalysisofmelanomabrainmetastasesmbmcomparedtoextracranialmetastasesecm